stars 1 stars 2 stars 3

Benchmark Genetics Tilapia operates an advanced family based breeding program for Nile tilapia, with breeding nucleus operations in Miami, Florida, USA. The Benchmark Genetics stock has been selected for key traits such as fast growth, survivability and yield, and more recently for increased resistance to Streptococcus iniae and S. agalactiae. Selection of disease resistance is based on controlled challenge testing of nucleus families. Additional key traits such as resistance to other pathogens, improved feed conversion efficiency, tolerance to salinity and high/low temperatures are currently assessed for implementation. Benchmark Genetics Tilapia is distributing genetically improved, high performing materials to integrated companies and affiliated multiplication hatcheries throughout the Americas, Asia and Europe.

Benchmark Genetics Tilapia Questions

The Benchmark Genetics Tilapia annual revenue was $14 million in 2026.

Hideyoshi Uno is the CEO of Benchmark Genetics Tilapia.

6 people are employed at Benchmark Genetics Tilapia.

Benchmark Genetics Tilapia is based in Miami, Florida.

The NAICS codes for Benchmark Genetics Tilapia are [112, 11].

The SIC codes for Benchmark Genetics Tilapia are [27, 2, 273].

Top Benchmark Genetics Tilapia Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users